Good time to enter CLDX! (1) rising trendline (2) Zacks Rank #2 = buy (short-term for next 1-3 months) (3) Zacks ABR (5 brokers) = 1.80 (almost strong buy); past brokers' recommendations = 2 holds, 3 buys, 0 strong buy, 0 sell, 0 strong sell (4) Zacks' Average Target Price = $6.63 (more than double current price of $3.03) (5) Risk-Reward ratio = 1:1+
What do you think of their P&L Statements? They are loosing money every Q.
TornAyro
⋅
@umbertocaba, true that CLDX has been losing money every quarter, but look on the bright side, it has also beat earnings expectations every quarter. For example, just this past 2018 first quarter, CLDX's expected EPS is -$0.25 but its actual EPS is -$0.17. This is good because the company is showing progress and a brighter future. As a result, the stock rose +17% in the last couple of days! And, if you follow my trading strategy, you would've made a decent profit from this spike up. Happy trading :)
umbertocaba
⋅
@TornAyro, as I said, loosing money evey Qtr and now without any products on the market and discontinuing clinical studies on their glembatumumab vedotin. There might be an opportunity to buy and hope another company acquires CLDX research team. What do you think?